Sub Banner Image

UK Approves Merck's Hypertension Drug Acquired Via $11 Billion Acceleron Pharma Deal

Market Impact

Vandana Singh

·

January 2, 2025

·

Benzinga

Merck's Winrevair (sotatercept) gains UK approval for PAH treatment. Key trial results highlight significant exercise capacity improvements.

read more

More from

Benzinga

More

Market Impact

Articles

Trending News

Enjoy premium content in your inbox.